DK4125911T3 - Obicetrapib til behandling af demens - Google Patents
Obicetrapib til behandling af demens Download PDFInfo
- Publication number
- DK4125911T3 DK4125911T3 DK22715162.8T DK22715162T DK4125911T3 DK 4125911 T3 DK4125911 T3 DK 4125911T3 DK 22715162 T DK22715162 T DK 22715162T DK 4125911 T3 DK4125911 T3 DK 4125911T3
- Authority
- DK
- Denmark
- Prior art keywords
- obicetrapib
- dementia
- treatment
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title 1
- NRWORBQAOQVYBJ-GJZUVCINSA-N obicetrapib Chemical compound N=1C=C(OCCCC(O)=O)C=NC=1N([C@H]1C[C@@H](CC)N(C2=CC=C(C=C21)C(F)(F)F)C(=O)OCC)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 NRWORBQAOQVYBJ-GJZUVCINSA-N 0.000 title 1
- 229950004285 obicetrapib Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Meat, Egg Or Seafood Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163157586P | 2021-03-05 | 2021-03-05 | |
| PCT/IB2022/000098 WO2022185120A1 (en) | 2021-03-05 | 2022-03-04 | Obicetrapib for treatment of dementias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4125911T3 true DK4125911T3 (da) | 2024-07-15 |
Family
ID=81327869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22715162.8T DK4125911T3 (da) | 2021-03-05 | 2022-03-04 | Obicetrapib til behandling af demens |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP4125911B1 (da) |
| JP (1) | JP2024513155A (da) |
| KR (1) | KR20230159457A (da) |
| CN (1) | CN117529319A (da) |
| AU (1) | AU2022231417A1 (da) |
| BR (1) | BR112023017999A2 (da) |
| CA (1) | CA3212483A1 (da) |
| DK (1) | DK4125911T3 (da) |
| FI (1) | FI4125911T3 (da) |
| IL (1) | IL305576A (da) |
| MX (1) | MX2023010211A (da) |
| WO (1) | WO2022185120A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202409008A (zh) | 2022-07-05 | 2024-03-01 | 荷蘭商新阿姆斯特丹製藥公司 | 奧比特拉(obicetrapib)鹽及彼等之製造方法與中間體 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA90269C2 (ru) * | 2004-04-02 | 2010-04-26 | Мицубиси Танабе Фарма Корпорейшн | Тетрагидрохинолиновые производные и способ их получения |
| JP4531027B2 (ja) * | 2005-09-29 | 2010-08-25 | 田辺三菱製薬株式会社 | 医薬組成物 |
| TW200808731A (en) | 2006-03-30 | 2008-02-16 | Tanabe Seiyaku Co | A process for preparing tetrahydroquinoline derivatives |
| EP2281824A1 (en) * | 2009-08-07 | 2011-02-09 | Noscira, S.A. | Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| WO2012050517A1 (en) * | 2010-10-14 | 2012-04-19 | Astrazeneca Ab | Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity |
| BR112016018077A8 (pt) * | 2014-02-05 | 2020-06-23 | Dezima Pharma B V | inibidor de proteína de transferência de éster colesterílico (composto a), composições farmacêuticas compreendendo o mesmo, método para preparação das referidas composições e uso do composto a |
| US10112904B2 (en) | 2014-08-12 | 2018-10-30 | Dezima Pharma B.V. | Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives |
-
2022
- 2022-03-04 MX MX2023010211A patent/MX2023010211A/es unknown
- 2022-03-04 KR KR1020237033972A patent/KR20230159457A/ko unknown
- 2022-03-04 IL IL305576A patent/IL305576A/en unknown
- 2022-03-04 DK DK22715162.8T patent/DK4125911T3/da active
- 2022-03-04 CA CA3212483A patent/CA3212483A1/en active Pending
- 2022-03-04 AU AU2022231417A patent/AU2022231417A1/en active Pending
- 2022-03-04 EP EP22715162.8A patent/EP4125911B1/en active Active
- 2022-03-04 EP EP24150094.1A patent/EP4368250A2/en active Pending
- 2022-03-04 WO PCT/IB2022/000098 patent/WO2022185120A1/en active Application Filing
- 2022-03-04 BR BR112023017999A patent/BR112023017999A2/pt unknown
- 2022-03-04 FI FIEP22715162.8T patent/FI4125911T3/fi active
- 2022-03-04 JP JP2023553588A patent/JP2024513155A/ja active Pending
- 2022-03-04 CN CN202280025877.9A patent/CN117529319A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN117529319A (zh) | 2024-02-06 |
| EP4368250A2 (en) | 2024-05-15 |
| WO2022185120A1 (en) | 2022-09-09 |
| IL305576A (en) | 2023-10-01 |
| EP4125911A1 (en) | 2023-02-08 |
| JP2024513155A (ja) | 2024-03-22 |
| CA3212483A1 (en) | 2022-09-09 |
| MX2023010211A (es) | 2023-11-22 |
| EP4125911B1 (en) | 2024-04-24 |
| KR20230159457A (ko) | 2023-11-21 |
| BR112023017999A2 (pt) | 2023-11-14 |
| AU2022231417A1 (en) | 2023-10-19 |
| FI4125911T3 (fi) | 2024-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3600270T3 (da) | Forbindelser og sammensætninger til behandling af hæmatologiske lidelser | |
| DK3402888T3 (da) | Middel og fremgangsmåder til behandling af hbv | |
| DK3504210T3 (da) | 7-substituerede sulfonimidoylpurinonforbindelser til behandling og forebyggelse af virusinfektion | |
| DK3491173T3 (da) | Fremgangsmåde og anlæg til fremstilling af methanol | |
| DK3668509T3 (da) | Fremgangsmåde til behandling af amyotrofisk lateralsklerose med pridopidin | |
| DK3506904T3 (da) | Behandling af demens | |
| DK3436074T3 (da) | Thiazolidforbindelser til behandling af virale infektioner | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3294740T3 (da) | Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3728410T3 (da) | Fremgangsmåde til behandling af lignocelluloseholdig biomasse | |
| DK3515455T3 (da) | Forbindelser til behandling af lidelser i lipoproteinmetabolismen | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3463328T3 (da) | Seladelpar til behandling af primær biliær cholangitis | |
| DK3256466T3 (da) | 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser | |
| DK3458467T3 (da) | Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener | |
| DK3478713T3 (da) | Sammensætninger til behandling af amyloidose | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK4101454T3 (da) | Sammensætninger til behandling af hypertension | |
| DK3286317T3 (da) | Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3743064T3 (da) | Behandling af proteinuri | |
| DK3737678T3 (da) | Fremgangsmåde til fremstilling af disubstituerede diaryloxybenzoheterodiazolforbindelser | |
| DK4125911T3 (da) | Obicetrapib til behandling af demens |